CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy

MLA

Cordero-Sanchez, Celia, et al. “CIC-39Na Reverses the Thrombocytopenia That Characterizes Tubular Aggregate Myopathy.” Blood Advances, vol. 6, no. 15, Aug. 2022, pp. 4471–84. EBSCOhost, https://doi.org/10.1182/bloodadvances.2021006378.

APA

Cordero-Sanchez, C., Pessolano, E., Riva, B., Vismara, M., Trivigno, S. M. G., Clemente, N., Aprile, S., Ruffinatti, F. A., Portararo, P., Filigheddu, N., Zaggia, I., Bhela, I. P., Serafini, M., Pirali, T., Colombo, M. P., Torti, M., Sangaletti, S., Bertoni, A., & Genazzani, A. A. (2022). CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy. Blood Advances, 6(15), 4471–4484. https://doi.org/10.1182/bloodadvances.2021006378

Chicago

Cordero-Sanchez, Celia, Emanuela Pessolano, Beatrice Riva, Mauro Vismara, Silvia Maria Grazia Trivigno, Nausicaa Clemente, Silvio Aprile, et al. 2022. “CIC-39Na Reverses the Thrombocytopenia That Characterizes Tubular Aggregate Myopathy.” Blood Advances 6 (15): 4471–84. doi:10.1182/bloodadvances.2021006378.